Renal Cancer - Results from #5540

How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies? September 27, 2016

Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy September 26, 2016

Overexpression of functional SLC6A3 in clear cell renal cell carcinoma September 26, 2016

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma September 26, 2016

Synchronous Type 1 Papillary Renal Cell Carcinoma in a Patient with Rectal Adenocarcinoma September 23, 2016

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma September 22, 2016

Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings September 21, 2016

Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale" September 21, 2016

Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma September 20, 2016

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma September 20, 2016

Cytomorphology of clear cell papillary renal cell carcinoma September 19, 2016

Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma September 16, 2016

Comparing Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Tumor Enucleation and Laparoscopic Partial Nephrectomy for Clinical T1a Renal Tumor: A Randomized Clinical Trial September 16, 2016

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy September 16, 2016

Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney September 16, 2016

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors September 15, 2016

Solitary parotid metastasis 8 years after a nephrectomy for renal cell carcinoma September 15, 2016

Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature September 14, 2016

Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma September 14, 2016

Perirenal Fat Promotes Renal Arterial Endothelial Dysfunction in Obese Swine through Tumor Necrosis Factor-a September 13, 2016

Page 278 of 456